secwatch.observer — SEC 8-K summary
======================================

Issuer:     Wellgistics Health, Inc. (WGRX)
CIK:        0002030763
Form:       8-K
Filed at:   2025-02-28T23:59:59+00:00
Accession:  0001493152-25-008723
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Wellgistics Health partners with Tollo Health to market medical foods for GLP-1 side effects and Long COVID
--------------------------------------------------------------------------------

- Consulting agreement with Hudson Global Ventures: $250,000 fee + 52,000 shares for 30-day advisory services.
- Subsidiary Wellgistics LLC signs agreement with Tollo Health to market Tollo's medical foods for GLP-1 muscle loss and Long COVID.
- Tollo's first product is Galectovid, a proprietary medical food for dietary management of viral infections.
- GLP-1 drug market cited at $46.7B, expected to grow to $322B by 2034; 16M working-age Americans have Long COVID.
- Wellgistics expects cross-selling to grow customer base and become key supplier in GLP-1 and Long COVID markets.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2030763/000149315225008723/0001493152-25-008723-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2030763/000149315225008723/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-008723

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer